Surgical Staging for Type II Endometrial Cancer: Laparotomy or Minimally Invasive Surgery?
A. Nickles Fader(Greater Baltimore Medical Center), Paola A. Gehrig(University of North Carolina at Chapel Hill), Heidi E. Frasure(University Hospitals of Cleveland), S. Rheaume(Duke University), John F. Boggess(University of Kentucky), M. Billow(Cleveland Clinic), Jeffrey M. Fowler(Columbus Center), Angeles Alvarez Secord(Duke University), G. Sfakanios(Duke University), Pedro F. Escobar(San Juan Bautista School of Medicine), K.M. Zanotti(University Hospitals of Cleveland), David E. Cohn(The Ohio State University), Leigh A. Cantrell(University of Virginia Health System), L. Havrilesky(Duke Medical Center), Leigh G. Seamon(The Ohio State University)
Cited by 1
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458